Study Of Nifurtimox Transfer Into Breastmilk In Lactating Women With Chagas Disease
Conditions:   Chagas Disease;   LactationIntervention:   Sponsors:   Hospital de Niños R. Gutierrez de Buenos Aires;   Hospital de Niños R. Gutierrez de Buenos AiresRecruiting - verified December 2012 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2012 Category: Research Source Type: clinical trials

Study Of Nifurtimox Transfer Into Breastmilk In Lactating Women With Chagas Disease
Conditions:   Chagas Disease;   LactationIntervention:   Sponsor:   Hospital de Niños R. Gutierrez de Buenos AiresCompleted - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2012 Category: Research Source Type: clinical trials

Study Of Nifurtimox Transfer Into Breastmilk In Lactating Women With Chagas Disease
Conditions:   Chagas Disease;   LactationIntervention:   Sponsors:   Hospital de Niños R. Gutierrez de Buenos Aires;   Hospital de Niños R. Gutierrez de Buenos AiresRecruiting - verified December 2012 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2012 Category: Research Source Type: clinical trials

Study Of Nifurtimox Transfer Into Breastmilk In Lactating Women With Chagas Disease
Conditions:   Chagas Disease;   LactationIntervention:   Sponsor:   Hospital de Niños R. Gutierrez de Buenos AiresCompleted - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2012 Category: Research Source Type: clinical trials

A Study of the Use of Oral Posaconazole (POS) in the Treatment of Asymptomatic Chronic Chagas Disease (P05267)
Condition:   Chagas DiseaseInterventions:   Drug: Posaconazole;   Drug: Placebo for posaconazole;   Drug: BenznidazoleSponsor:   Merck Sharp & Dohme Corp.Active, not recruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 13, 2011 Category: Research Source Type: clinical trials

A Study of the Use of Oral Posaconazole (POS) in the Treatment of Asymptomatic Chronic Chagas Disease (P05267)
Condition:   Chagas DiseaseInterventions:   Drug: Posaconazole;   Drug: Placebo for posaconazole;   Drug: BenznidazoleSponsor:   Merck Sharp & Dohme Corp.Completed - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 13, 2011 Category: Research Source Type: clinical trials